Why is ebola so deadly

Overview

Ebola virus disease (EVD) is a severe, often fatal illness in humans caused by the Ebola virus, first identified in 1976 during two simultaneous outbreaks in Nzara, South Sudan and Yambuku, Democratic Republic of Congo. The virus gets its name from the Ebola River near the Congolese outbreak site. Since its discovery, there have been over 30 outbreaks, primarily in Central and West Africa. The largest outbreak occurred from 2014-2016 in West Africa, affecting Guinea, Liberia, and Sierra Leone, with 28,616 reported cases and 11,310 deaths according to WHO statistics. The virus is transmitted to people from wild animals (fruit bats are considered the natural host) and spreads through human-to-human transmission via direct contact with bodily fluids. The incubation period ranges from 2 to 21 days, and symptoms typically include fever, severe headache, muscle pain, weakness, diarrhea, vomiting, abdominal pain, and unexplained hemorrhage.

How It Works

Ebola's deadliness stems from its ability to hijack human cells and evade the immune system. The virus enters the body through mucous membranes or breaks in the skin, then targets immune cells called macrophages and dendritic cells. Once inside these cells, Ebola replicates rapidly, producing viral proteins that interfere with the body's immune response. One key mechanism involves the virus's glycoprotein, which attaches to host cell receptors and facilitates entry. Ebola also produces proteins that inhibit interferon production, a crucial part of the antiviral defense system. As the infection progresses, the virus damages blood vessels, leading to hemorrhagic symptoms as it causes endothelial cells lining blood vessels to become permeable. This vascular damage results in internal and external bleeding, organ failure, and septic shock. The virus spreads through direct contact with infected blood, secretions, organs, or other bodily fluids, and can persist in certain bodily fluids like semen for months after recovery.

Why It Matters

Ebola's significance extends beyond its high mortality rate to its devastating impact on communities and healthcare systems. Outbreaks often overwhelm local medical facilities, disrupt essential services, and cause economic losses. The 2014-2016 West African outbreak cost an estimated $53 billion in economic and social impact according to World Bank data. Ebola also highlights global health security vulnerabilities, demonstrating how quickly infectious diseases can spread in our interconnected world. The disease has spurred international cooperation on outbreak response, led to the development of vaccines (with rVSV-ZEBOV vaccine showing 97.5% efficacy in a 2019 trial), and improved global surveillance systems. Understanding Ebola's mechanisms continues to inform research on other hemorrhagic fevers and pandemic preparedness.